Accumulation of phosphorylated tyrosine hydroxylase into insoluble protein aggregates by inhibition of an ubiquitin-proteasome system in PC12D cells
Abstract
Tyrosine hydroxylase (TH) is a rate-limiting enzyme for the biosynthesis of catecholamines including dopamine. The relationship between proteasomal dysfunction and the etiology of Parkinson's disease has been suggested, but it is unknown if TH protein is affected by proteasomal dysfunctions. Here, we examined the effect of inhibition of ubiquitin-proteasomal pathway on biochemical characteristics of TH protein in the neuronal cells. Inhibition of 20S or 26S proteasome by proteasome inhibitor I, or MG-132 in NGF-differentiated PC12D cells induced dot-like immunoreactivities with the anti-(40)Ser-phosphorylated TH (p40-TH) antibody. These dots were tightly co-localized with ubiquitin and positive to Thioflavine-S staining. These dot-like immunoreactivities were not obvious when immunostaining was performed against total-TH or choline acetyltransferase. Western blotting analysis showed time-dependent increase of p40-TH in the Triton-insoluble fractions. We also examined the effect of okadaic acid, an inhibitor of protein phosphatase 2A, which is a phosphatase acting on p40-TH. Okadaic acid increased the amount of insoluble p40-TH. These data suggest that p40-TH is prone to be insolubilized and aggregated by dysfunction of an ubiquitin-proteasome system in PC12D cells.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
TH protein, particularly phosphorylated TH, forms intracellular aggregates easily.
“TH protein, particularly phosphorylated TH, apparently forms intracellular aggregates easily [70,72].”
From Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease and Dopa-Responsive Dystonia (2020) · cites this paper as [70]
Proteasomal inhibition leads to accumulation of pSer40-TH, which is ubiquitin-immunopositive, in NGF-differentiated PC12D cells.
“we previously found that proteasomal inhibition leads to accumulation of pSer40-TH, which is ubiquitin-immunopositive, in nerve growth factor (NGF)-differentiated PC12D cells [70].”
From Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease and Dopa-Responsive Dystonia (2020) · cites this paper as [70]
26S proteasomal inhibition leads to formation of insoluble inclusions of pSer40-TH in NGF-differentiated PC12D cells.
“We further revealed that 26S proteasomal inhibition leads to accumulation of TH phosphorylated at Ser40 (pSer40-TH), which are ubiquitin-positive, as well as formation of its insoluble inclusions in NGF-differentiated PC12D cells [70].”
From Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease and Dopa-Responsive Dystonia (2020) · cites this paper as [70]
Proteasomal inhibition results in TH aggregation, whereas choline acetyltransferase does not show such aggregations.
“Interestingly, proteasomal inhibition results in TH aggregation, whereas choline acetyltransferase does not show such aggregations [70].”
From Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease and Dopa-Responsive Dystonia (2020) · cites this paper as [70]
The citation lists haven’t been fetched yet
References 29 · Cited by 31
- Authors
- Kawahata, I., Tokuoka, H., Parvez, H., & Ichinose, H.
- Affiliations
- Tokyo Institute of Technology (JP)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Ichinose, Hiroshi
- Venue
- Journal of Neural Transmission
- Published
- 2009-09-12
- Volume
- 116
- Issue
- 12
- Pages
- 1571-1578
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2013120967
- Cited by
- 31
- References
- 29
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 5 · 2020: 4 · 2019: 1 · 2018: 1 · 2016: 3 · 2015: 3 · 2014: 3 · 2013: 1 · 2012: 2
- FWCI
- 0.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Tokyo Tech Research Repository (Tokyo Institute of Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Keywords
- tyrosine hydroxylase, protein aggregation, ubiquitin-proteasome system, proteasome inhibition, Parkinson's disease, PC12D cells, dopamine synthesis, protein phosphatase 2A, okadaic acid, proteasomal dysfunction
- MeSH terms
- Animals, Choline O-Acetyltransferase, Enzyme Inhibitors, Leupeptins, Neurons, Oligopeptides, Phosphorylation, Time Factors, Tyrosine 3-Monooxygenase, Cysteine Proteinase Inhibitors, PC12 Cells, Okadaic Acid, Ubiquitin, Proteasome Endopeptidase Complex, Rats, Protein Phosphatase 2, Protein Multimerization, Proteasome Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review